Astellas Pharma Inc. established an open innovation base for cancer microenvironmental research using state-of-the-art spatial biology at Mitsui Fudosan’s Mitsui Link Lab Kashiwa-no-ha 1.

Astellas Pharma Inc.
Mitsui Fudosan Co., Ltd.

Astellas Pharma Inc. (Headquarters: Chuo-ku, Tokyo; President and CEO: Naoki Okamura; hereinafter "Astellas Pharma Inc.") and Mitsui Fudosan Co., Ltd. (Headquarters: Chuo-ku, Tokyo; President and CEO: Toshi Ueda; hereinafter "Mitsui Fudosan") are pleased to announce that Astellas Pharma Inc.'s open innovation base, "TME (Tumor MicroEnvironment) imaging and interactive research for innovation (TME iLab)" operated by Mitsui Fudosan in October 2023 in Kashiwa City, Chiba Prefecture.

Click here for more information

Return to the list

Astellas Pharma Inc. established an open innovation base for cancer microenvironmental research using state-of-the-art spatial biology at Mitsui Fudosan’s Mitsui Link Lab Kashiwa-no-ha 1.

Contact

Those who are looking for materials in brochure format

Those who want to know about private viewings and rents